Grail CSO Vikram Bajaj jumps to VC firm Foresite, takes lead on personalized meds
After just one year on the job, Vikram Bajaj has left his post as chief scientific officer of cancer biotech Grail and is joining investment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
